Zogenix Raises $51 Million

Zogenix Inc., a San Diego-based drug company focused on pain management and CNS disorders, has raised $51 million in new VC funding. Clarus Ventures and Domain Associates co-led the round, and were joined by fellow return backers Scale Venture Partners, Thomas, McNerney & Partners, Oxford Finance Corp. and Abingworth Management. The round is structured with an initial $36 million call-down and $15 million in a second tranche callable by the company's board. Zogenix canceled an $86.25 million IPO last summer.

North AmericaUSBriefs